Table 1.
Demographics of INVEST-GENES Case Control Data Set
| Characteristic (N, % unless otherwise noted) |
Cases (N=297) |
Controls (N=762) |
|---|---|---|
| Age, mean (SD), years* | 71.4 (9.8) | 70.2 (9.3) |
| Women | 148 (49.8) | 387 (50.8) |
| Race/ethnicity | ||
| White | 185 (62.3) | 462 (60.6) |
| Hispanic | 70 (23.6) | 197 (25.9) |
| Black | 41 (13.8) | 100 (13.1) |
| Other/multiracial | 1 (0.3) | 3 (0.4) |
| BP, mean (SD), mm HG | ||
| Systolic* | 150.6 (18.7) | 147.4 (18.9) |
| Diastolic | 83.3 (11) | 83.4 (11.1) |
| BMI, mean (SD), kg/m2* | 27.5 (4.8) | 28.9 (5.5) |
| Medical history | ||
| Prior myocardial infarction* | 107 (36) | 225 (29.5) |
| Stable angina | 181 (60.9) | 476 (62.5) |
| Prior stroke/TIA* | 44 (14.8) | 67 (8.8) |
| Left Ventricular Hypertrophy | 56 (18.9) | 132 (17.3) |
| Heart failure (class I-III)* | 31 (10.4) | 27 (3.5) |
| Peripheral vascular disease* | 50 (16.8) | 86 (11.3) |
| Smoking Ever | 154 (51.9) | 349 (45.8) |
| Diabetes*@ | 90 (30.3) | 170 (22.3) |
| Hypercholesterolemia@ | 184 (62) | 475 (62.3) |
| Renal Impairment* | 15 (5.1) | 17 (2.2) |
| Cancer | 25 (8.4) | 44 (5.8) |
Abbreviations: BP, blood pressure, BMI, body mass index, TIA, transient ischemic attack.
*
Indicates p<0.05.
@
Diabetes/Hypercholesterolemia defined as history or currently taking anti-diabetic or lipid-lowering medications